Concepedia

Michelle Mojadidi

MM

Statistics

Publications

5

Citations

333

H-Index

5

Active since

2010

Affiliations

University of California, Los Angeles(Current)

Kite (United States)

Michelle Mojadidi is an author at University of California, Los Angeles specializing in cancer therapeutics, t cell immunity, and tumor immunity.

Top concepts

Publications per year

2010–2017

5

Publications

5

CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells

Megan D. Hoban, Dianne Lumaquin, Caroline Y. Kuo et al. · Molecular Therapy · 2016 · 213 citations · Full text

Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases

Michelle Mojadidi, John W. Phillips, Caroline Y. Kuo et al. · Molecular Therapy — Nucleic Acids · 2016 · 56 citations · Full text

A phase I/II clinical trial of E6 T-cell receptor gene therapy for human papillomavirus (HPV)-associated epithelial cancers.

Christian S. Hinrichs, Stacey L. Doran, Sanja Stevanović et al. · Journal of Clinical Oncology · 2017 · 32 citations

, , +21

Bioluminescence Imaging of Angiogenesis in a Murine Orthotopic Pancreatic Cancer Model

Eliane Angst, Monica F. Chen, Michelle Mojadidi et al. · Molecular Imaging and Biology · 2010 · 20 citations · Full text

Phase 1 Results of ZUMA-3: KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL)

Bijal Shah, Wendy Stock, William G. Wierda et al. · Blood · 2017 · 12 citations

1–5 of 5